1,512
Views
50
CrossRef citations to date
0
Altmetric
Review Article

Common and specific genes and peripheral biomarkers in children and adults with attention-deficit/hyperactivity disorder

, &
Pages 80-100 | Received 27 Sep 2016, Accepted 02 Jan 2017, Published online: 24 Feb 2017

References

  • Akutagava-Martins GC, Salatino-Oliveira A, Bruxel EM, Genro JP, Mota NR, Polanczyk GV, Zeni CP, Grevet EH, Bau CH, Rohde LA, et al. 2014a. Lack of association between the GRM7 gene and attention deficit hyperactivity disorder. Psychiatr Genet. 24:281–282.
  • Akutagava-Martins GC, Salatino-Oliveira A, Genro JP, Contini V, Polanczyk G, Zeni C, Chazan R, Kieling C, Anselmi L, Menezes AM, et al. 2014b. Glutamatergic copy number variants and their role in attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 165B:502–509.
  • Arcos-Burgos M, Jain M, Acosta MT, Shively S, Stanescu H, Wallis D, Domené S, Vélez JI, Karkera JD, Balog J, et al. 2010. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry. 15:1053–1066.
  • Baird AL, Coogan AN, Siddiqui A, Donev RM, Thome J. 2012. Adult attention-deficit hyperactivity disorder is associated with alterations in circadian rhythms at the behavioural, endocrine and molecular levels. Mol Psychiatry. 17:988–995.
  • Biederman J, Faraone SV, Mick E, Spencer T, Wilens T, Kiely K, Guite J, Ablon JS, Reed E, Warburton R. 1995. High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study. Am J Psychiatry. 152:431–435.
  • Biederman J, Faraone S, Milberger S, Curtis S, Chen L, Marrs A, Ouellette C, Moore P, Spencer T. 1996. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 35:343–351.
  • Biederman J, Mick E, Faraone SV. 2000. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 157:816–818.
  • Bonvicini C, Faraone SV, Scassellati C. 2016. Attention-deficit hyperactivity disorder in adults: a systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies. Mol Psychiatry. 21:872–884.
  • Boomsma DI, Saviouk V, Hottenga JJ, Distel MA, de Moor MH, Vink JM, Geels LM, van Beek JH, Bartels M, de Geus EJ, et al. 2010. Genetic epidemiology of attention deficit hyperactivity disorder (ADHD index) in adults. PLoS One. 5:e10621.
  • Bralten J, Franke B, Waldman I, Rommelse N, Hartman C, Asherson P, Banaschewski T, Ebstein RP, Gill M, Miranda A, et al. 2013. Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD. J Am Acad Child Adolesc Psychiatry. 52:1204–1212.e1.
  • Brikell I, Kuja-Halkola R, Larsson H. 2015. Heritability of attention-deficit hyperactivity disorder in adults. Am J Med Genet B Neuropsychiatr Genet. [Epub ahead of print]. doi:10.1002/ajmg.b.32335
  • Ceylan M, Sener S, Bayraktar AC, Kavutcu M. 2010. Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 34:1491–1494.
  • Ceylan MF, Sener S, Bayraktar AC, Kavutcu M. 2012. Changes in oxidative stress and cellular immunity serum markers in attention-deficit/hyperactivity disorder. Psychiatry Clin Neurosci. 66:220–226.
  • Chang Z, Lichtenstein P, Asherson PJ, Larsson H. 2013. Developmental twin study of attention problems: high heritabilities throughout development. JAMA Psychiatry. 70:311–318.
  • Coogan AN, Baird AL, Popa-Wagner A, Thome J. 2016. Circadian rhythms and attention deficit hyperactivity disorder: the what, the when and the why. Prog Neuropsychopharmacol Biol Psychiatry. 67:74–81.
  • Corominas-Roso M, Ramos-Quiroga JA, Ribases M, Sanchez-Mora C, Palomar G, Valero S, Bosch R, Casas M. 2013. Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 30:1–9.
  • de Azeredo LA, Rovaris DL, Mota NR, Polina ER, Marques FZ, Contini V, Vitola ES, Belmonte-de-Abreu P, Rohde LA, Grevet EH, et al. 2014. Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults. Eur Arch Psychiatry Clin Neurosci. 264:401–408.
  • De Luca V, Muglia P, Jain U, Basile VS, Sokolowski MB, Kennedy JL. 2002. A drosophila model for attention deficit hyperactivity disorder (ADHD): no evidence of association with PRKG1 gene. Neuromolecular Med. 2:281–287.
  • Drtilkova I, Sery O, Theiner P, Uhrova A, Zackova M, Balastikova B, Znojil V. 2008. Clinical and molecular-genetic markers of ADHD in children. Neuro Endocrinol Lett. 29:320–327.
  • Elia J, Devoto M. 2007. ADHD genetics: 2007 update. Curr Psychiatry Rep. 9:434–439.
  • Elia J, Gai X, Xie HM, Perin JC, Geiger E, Glessner JT, D'arcy M, deBerardinis R, Frackelton E, Kim C, et al. 2010. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry. 15:637–646.
  • Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, Rohde LA, Sonuga-Barke EJS, Tannock R, Franke B. 2015. Attention deficit hyperactivity disorder. Nat Rev Dis Prime. 1:15020.
  • Faraone SV, Biederman J, Feighner JA, Monuteaux MC. 2000b. Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid? J Consult Clin Psychol. 68:830–842.
  • Faraone SV, Biederman J, Mick E. 2006. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 36:159–165.
  • Faraone SV, Biederman J, Monuteaux MC. 2000a. Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genet Epidemiol. 18:1–16.
  • Faraone SV, Bonvicini C, Scassellati C. 2014a. Biomarkers in the diagnosis of ADHD-promising directions. Curr Psychiatry Rep. 16:497.
  • Faraone SV, Mick E. 2010. Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am. 33:159–180.
  • Faraone SV, Spencer TJ, Madras BK, Zhang-James Y, Biederman J. 2014b. Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis. Mol Psychiatry. 19:880–889.
  • Franke B, Faraone SV, Asherson P, Buitelaar J, Bau CH, Ramos-Quiroga JA, Mick E, Grevet EH, Johansson S, Haavik J, et al. 2012. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry. 17:960–987.
  • Gao Q, Liu L, Qian Q, Wang Y. 2014. Advances in molecular genetic studies of attention deficit hyperactivity disorder in china. Shanghai Arch Psychiatry. 26:194–206.
  • Genro JP, Kieling C, Rohde LA, Hutz MH. 2010. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses. Expert Rev Neurother. 10:587–601.
  • Gizer IR, Ficks C, Waldman ID. 2009. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 126:51–90.
  • Gomez-Sanchez CI, Riveiro-Alvarez R, Soto-Insuga V, Rodrigo M, Tirado-Requero P, Mahillo-Fernandez I, Abad-Santos F, Carballo JJ, Dal-Re R, Ayuso C. 2016. Attention deficit hyperactivity disorder: genetic association study in a cohort of spanish children. Behav Brain Funct. 12:2.
  • Grady DL, Chi HC, Ding YC, Smith M, Wang E, Schuck S, Flodman P, Spence MA, Swanson JM, Moyzis RK. 2003. High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder. Mol Psychiatry. 8:536–545.
  • Grunblatt E, Geissler J, Jacob CP, Renner T, Muller M, Bartl J, Gross-Lesch S, Riederer P, Lesch KP, Walitza S, et al. 2012. Pilot study: potential transcription markers for adult attention-deficit hyperactivity disorder in whole blood. Atten Defic Hyperact Disord. 4:77–84.
  • Guan L, Wang B, Chen Y, Yang L, Li J, Qian Q, Wang Z, Faraone SV, Wang Y. 2009. A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population. Mol Psychiatry. 14:546–554.
  • Guney E, Ceylan MF, Kara M, Tekin N, Goker Z, Senses Dinc G, Ozturk O, Eker S, Kizilgun M. 2014. Serum nerve growth factor (NGF) levels in children with attention deficit/hyperactivity disorder (ADHD). Neurosci Lett. 560:107–111.
  • Hasler R, Salzmann A, Bolzan T, Zimmermann J, Baud P, Giannakopoulos P, Perroud N. 2015. DAT1 and DRD4 genes involved in key dimensions of adult ADHD. Neurol Sci. 36:861–869.
  • Hawi Z, Cummins TD, Tong J, Johnson B, Lau R, Samarrai W, Bellgrove MA. 2015. The molecular genetic architecture of attention deficit hyperactivity disorder. Mol Psychiatry. 20:289–297.
  • Hawi Z, Matthews N, Barry E, Kirley A, Wagner J, Wallace RH, Heussler HS, Vance A, Gill M, Bellgrove MA. 2013. A high density linkage disequilibrium mapping in 14 noradrenergic genes: evidence of association between SLC6A2, ADRA1B and ADHD. Psychopharmacology (Berl). 225:895–902.
  • Herken H, Erdal ME, Kenar AN, Unal GA, Cakaloz B, Ay ME, Yücel E, Edgünlü T, Sengül C. 2014. Association of SNAP-25 gene ddel and MNLL polymorphisms with adult attention deficit hyperactivity disorder. Psychiatry Investig. 11:476–480.
  • Hinney A, Scherag A, Jarick I, Albayrak Ö, Pütter C, Pechlivanis S, Dauvermann MR, Beck S, Weber H, Scherag S, et al. 2011. Genome-wide association study in German patients with attention deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 156B:888–897.
  • Hwang IW, Lim MH, Kwon HJ, Jin HJ. 2015. Association of LPHN3 rs6551665 A/G polymorphism with attention deficit and hyperactivity disorder in korean children. Gene. 566:68–73.
  • Jacob CP, Weber H, Retz W, Kittel-Schneider S, Heupel J, Renner T, Lesch KP, Reif A. 2013. Acetylcholine-metabolizing butyrylcholinesterase (BCHE) copy number and single nucleotide polymorphisms and their role in attention-deficit/hyperactivity syndrome. J Psychiatr Res. 47:1902–1908.
  • Jacobsen KK, Halmoy A, Sanchez-Mora C, Ramos-Quiroga JA, Cormand B, Haavik J, Johansson S. 2013. DISC1 in adult ADHD patients: an association study in two European samples. Am J Med Genet B Neuropsychiatr Genet. 162B:227–234.
  • Joseph N, Zhang-James Y, Perl A, Faraone SV. 2015. Oxidative stress and ADHD: a meta-analysis. J Atten Disord. 19:915–924.
  • Kan KJ, Dolan CV, Nivard MG, Middeldorp CM, van Beijsterveldt CE, Willemsen G, Boomsma DI. 2013. Genetic and environmental stability in attention problems across the lifespan: evidence from the Netherlands twin register. J Am Acad Child Adolesc Psychiatry. 52:12–25.
  • Kandemir H, Erdal ME, Selek S, Ay Öİ, Karababa IF, Kandemir SB, Ay ME, Yılmaz ŞG, Bayazıt H, Taşdelen B. 2014. Evaluation of several micro RNA (miRNA) levels in children and adolescents with attention deficit hyperactivity disorder. Neurosci Lett. 580:158–162.
  • Kayyal M, Movafagh A, Hashemi M, Sayad A, Emamalizadeh B, PourIran K, Kayyal M, Amirabadi MR, Zamani M, Darvish H. 2015. Association analysis of DISC1 gene polymorphisms with attention-deficit hyperactivity disorder in Iranian population. Pak J Med Sci. 31:1162–1166.
  • Kenar AN, Ay O, Herken H, Erdal ME. 2014. Association of VAMP-2 and syntaxin 1A genes with adult attention deficit hyperactivity disorder. Psychiatry Investig. 11:76–83.
  • Kissling C, Retz W, Wiemann S, Coogan AN, Clement RM, Hünnerkopf R, Conner AC, Freitag CM, Rösler M, Thome J. 2008. A polymorphism at the 3′-untranslated region of the CLOCK gene is associated with adult attention-deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 147:333–338.
  • Kittel-Schneider S, Reuß M, Meyer A, Weber H, Gessner A, Leistner C, Kopf J, Schmidt B, Hempel S, Volkert J, et al. 2015. Multi-level biomarker analysis of nitric oxide synthase isoforms in bipolar disorder and adult ADHD. J Psychopharmacol (Oxford). 29:31–38.
  • Landaas ET, Johansson S, Halmoy A, Oedegaard KJ, Fasmer OB, Haavik J. 2011. Bipolar disorder risk alleles in adult ADHD patients. Genes Brain Behav. 10:418–423.
  • Landaas ET, Johansson S, Jacobsen KK, Ribasés M, Bosch R, Sánchez-Mora C, Jacob CP, Boreatti-Hümmer A, Kreiker S, Lesch KP, et al. 2010. An international multicenter association study of the serotonin transporter gene in persistent ADHD. Genes Brain Behav. 9:449–458.
  • Langley K, Fowler TA, Grady DL, Moyzis RK, Holmans PA, van den Bree MB, Owen MJ, O'Donovan MC, Thapar A. 2009. Molecular genetic contribution to the developmental course of attention-deficit hyperactivity disorder. Eur Child Adolesc Psychiatry. 18:26–32.
  • Larsson H, Asherson P, Chang Z, Ljung T, Friedrichs B, Larsson JO, Lichtenstein P. 2013. Genetic and environmental influences on adult attention deficit hyperactivity disorder symptoms: a large swedish population-based study of twins. Psychol Med. 43:197–207.
  • Larsson H, Lichtenstein P, Larsson JO. 2006. Genetic contributions to the development of ADHD subtypes from childhood to adolescence. J Am Acad Child Adolesc Psychiatry. 45:973–981.
  • Lasky-Su J, Neale BM, Franke B, Anney RJ, Zhou K, Maller JB, Vasquez AA, Chen W, Asherson P, Buitelaar J, et al. 2008. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet. 147B:1345–1354.
  • Laurin N, Lee J, Ickowicz A, Pathare T, Malone M, Tannock R, Kennedy JL, Schachar RJ, Barr CL. 2008. Association study for genes at chromosome 5p13-q11 in attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 147B:600–605.
  • Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, et al. 2013. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 45:984–994.
  • Lee YH, Song GG. 2015. BDNF 196 G/A and COMT Val158Met polymorphisms and susceptibility to ADHD: A meta-analysis. J Atten Disord. [Epub ahead of print] doi:10.1177/1087054715570389
  • Lesch KP, Selch S, Renner TJ, Jacob C, Nguyen TT, Hahn T, Romanos M, Walitza S, Shoichet S, Dempfle A, et al. 2011. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol Psychiatry. 16:491–503.
  • Lesch KP, Timmesfeld N, Renner TJ, Halperin R, Röser C, Nguyen TT, Craig DW, Romanos J, Heine M, Meyer J, et al. 2008. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm (Vienna). 115:1573–1585.
  • Li Z, Chang SH, Zhang LY, Gao L, Wang J. 2014. Molecular genetic studies of ADHD and its candidate genes: a review. Psychiatry Res. 219:10–24.
  • Lionel AC, Crosbie J, Barbosa N, Goodale T, Thiruvahindrapuram B, Rickaby J, Gazzellone M, Carson AR, Howe JL, Wang Z, et al. 2011. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med. 3:95ra75.
  • Liu L, Chen Y, Li H, Qian Q, Yang L, Glatt SJ, Faraone SV, Wang Y. 2013a. Association between SYP with attention-deficit/hyperactivity disorder in chinese han subjects: differences among subtypes and genders. Psychiatry Res. 210:308–314.
  • Liu L, Sun L, Li ZH, Li HM, Wei LP, Wang YF, Qian QJ. 2013b. BAIAP2 exhibits association to childhood ADHD especially predominantly inattentive subtype in Chinese Han subjects. Behav Brain Funct. 9:48.
  • Martin J, O'Donovan MC, Thapar A, Langley K, Williams N. 2015. The relative contribution of common and rare genetic variants to ADHD. Transl Psychiatry. 5:e506.
  • Mavroconstanti T, Halmoy A, Haavik J. 2014. Decreased serum levels of adiponectin in adult attention deficit hyperactivity disorder. Psychiatry Res. 216:123–130.
  • Mavroconstanti T, Johansson S, Winge I, Knappskog PM, Haavik J. 2013. Functional properties of rare missense variants of human CDH13 found in adult attention deficit/hyperactivity disorder (ADHD) patients. PLoS One. 8:e71445.
  • Neale BM, Lasky-Su J, Anney R, Franke B, Zhou K, Maller JB, Vasquez AA, Asherson P, Chen W, Banaschewski T, et al. 2008. Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 147B:1337–1344.
  • Neale BM, Medland S, Ripke S, Anney RJ, Asherson P, Buitelaar J, Franke B, Gill M, Kent L, Holmans P, et al. 2010. Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 49:906–920.
  • Ogdie MN, Bakker SC, Fisher SE, Francks C, Yang MH, Cantor RM, Loo SK, van der Meulen E, Pearson P, Buitelaar J, et al. 2006. Pooled genome-wide linkage data on 424 ADHD ASPs suggests genetic heterogeneity and a common risk locus at 5p13. Mol Psychiatry. 11:5–8.
  • Olgiati P, Mandelli L, Alberti S, Lia L, Serretti A, Tiwari AK, Jain U, Kennedy JL, Muller DJ. 2014. Role of synaptosome-related (SNARE) genes in adults with attention deficit hyperactivity disorder. Psychiatry Res. 215:799–800.
  • Ozcan O, Arslan M, Gungor S, Yuksel T, Selimoglu MA. 2015. Plasma leptin, adiponectin, neuropeptide Y levels in drug naive children with ADHD. J Atten Disord. [Epub ahead of print] doi:10.1177/1087054715587095
  • Pan YQ, Qiao L, Xue XD, Fu JH. 2015. Association between ANKK1 (rs1800497) polymorphism of DRD2 gene and attention deficit hyperactivity disorder: a meta-analysis. Neurosci Lett. 590:101–105.
  • Poelmans G, Pauls DL, Buitelaar JK, Franke B. 2011. Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. Am J Psychiatry. 168:365–377.
  • Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. 2007. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 164:942–948.
  • Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. 2014. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol. 43:434–442.
  • Ramos-Quiroga JA, Nasillo V, Fernandez-Aranda F, Fernandez-Arana F, Casas M. 2014a. Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother. 14:553–567.
  • Ramos-Quiroga JA, Sánchez-Mora C, Casas M, Garcia-Martínez I, Bosch R, Nogueira M, Corrales M, Palomar G, Vidal R, Coll-Tané M, et al. 2014b. Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder. J Psychiatr Res. 49:60–67.
  • Reif A, Nguyen TT, Weissflog L, Jacob CP, Romanos M, Renner TJ, Buttenschon HN, Kittel-Schneider S, Gessner A, Weber H, et al. 2011. DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders. Neuropsychopharmacology. 36:2318–2327.
  • Ribases M, Bosch R, Hervás A, Ramos-Quiroga JA, Sanchez-Mora C, Bielsa A, Gastaminza X, Guijarro-Domingo S, Nogueira M, Gomez-Barros N, et al. 2009b. Case-control study of six genes asymmetrically expressed in the two cerebral hemispheres: association of BAIAP2 with attention-deficit/hyperactivity disorder. Biol Psychiatry. 66:926–934.
  • Ribases M, Hervás A, Ramos-Quiroga JA, Bosch R, Bielsa A, Gastaminza X, Fernández-Anguiano M, Nogueira M, Gómez-Barros N, Valero S, et al. 2008. Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder. Biol Psychiatry. 63:935–945.
  • Ribases M, Ramos-Quiroga JA, Hervás A, Bosch R, Bielsa A, Gastaminza X, Artigas J, Rodriguez-Ben S, Estivill X, Casas M, et al. 2009a. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Mol Psychiatry. 14:71–85.
  • Ribases M, Ramos-Quiroga JA, Hervás A, Sanchez-Mora C, Bosch R, Bielsa A, Gastaminza X, Lesch KP, Reif A, Renner TJ, et al. 2012. Candidate system analysis in ADHD: evaluation of nine genes involved in dopaminergic neurotransmission identifies association with DRD1. World J Biol Psychiatry. 13:281–292.
  • Ribases M, Ramos-Quiroga JA, Sanchez-Mora C, Bosch R, Richarte V, Palomar G, Gastaminza X, Bielsa A, Arcos-Burgos M, Muenke M, et al. 2011. Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study. Genes Brain Behav. 10:149–157.
  • Sánchez-Mora C, Cormand B, Ramos-Quiroga JA, Hervás A, Bosch R, Palomar G, Nogueira M, Gómez-Barros N, Richarte V, Corrales M, et al. 2013a. Evaluation of common variants in 16 genes involved in the regulation of neurotransmitter release in ADHD. Eur Neuropsychopharmacol. 23:426–435.
  • Sanchez-Mora C, Ramos-Quiroga JA, Bosch R, Corrales M, Garcia-Martinez I, Nogueira M, Pagerols M, Palomar G, Richarte V, Vidal R, et al. 2015b. Case-control genome-wide association study of persistent attention-deficit hyperactivity disorder identifies FBXO33 as a novel susceptibility gene for the disorder. Neuropsychopharmacology. 40:915–926.
  • Sánchez-Mora C, Ramos-Quiroga JA, Garcia-Martínez I, Fernàndez-Castillo N, Bosch R, Richarte V, Palomar G, Nogueira M, Corrales M, Daigre C, et al. 2013b. Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs). Eur Neuropsychopharmacol. 23:1463–1473.
  • Sánchez-Mora C, Ribasés M, Casas M, Bayés M, Bosch R, Fernàndez-Castillo N, Brunso L, Jacobsen KK, Landaas ET, Lundervold AJ, et al. 2011. Exploring DRD4 and its interaction with SLC6A3 as possible risk factors for adult ADHD: a meta-analysis in four European populations. Am J Med Genet B Neuropsychiatr Genet. 156B:600–612.
  • Sanchez-Mora C, Richarte V, Garcia-Martínez I, Pagerols M, Corrales M, Bosch R, Vidal R, Viladevall L, Casas M, Cormand B, et al. 2015a. Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 168:480–491.
  • Salatino-Oliveira A, Akutagava-Martins GC, Bruxel EM, Genro JP, Polanczyk GV, Zeni C, Kieling C, Karam RG, Rovaris DL, Contini V, et al. 2016. NOS1 and SNAP25 polymorphisms are associated with attention-deficit/hyperactivity disorder symptoms in adults but not in children. J Psychiatr Res. 75:75–81.
  • Salatino-Oliveira A, Genro JP, Polanczyk G, Zeni C, Schmitz M, Kieling C, Anselmi L, Menezes AM, Barros FC, Polina ER, et al. 2015. Cadherin-13 gene is associated with hyperactive/impulsive symptoms in attention/deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 168B:162–169.
  • Scassellati C, Bonvicini C. 2015. Role of dopaminergic and noradrenergic systems as potential biomarkers in ADHD diagnosis and treatment. In: Norvilitis JM, editor. ADHD: new directions in diagnosis and treatment. Rijeka: InTech.
  • Scassellati C, Bonvicini C, Faraone SV, Gennarelli M. 2012. Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses. J Am Acad Child Adolesc Psychiatry. 51:1003–1019.e20.
  • Scassellati C, Zanardini R, Tiberti A, Pezzani M, Valenti V, Effedri P, Filippini E, Conte S, Ottolini A, Gennarelli M, et al. 2014. Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 23:173–177.
  • Shaw P, Gornick M, Lerch J, Addington A, Seal J, Greenstein D, Sharp W, Evans A, Giedd JN, Castellanos FX, et al. 2007. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 64:921–931.
  • Shaw P, Malek M, Watson B, Greenstein D, de Rossi P, Sharp W. 2013. Trajectories of cerebral cortical development in childhood and adolescence and adult attention-deficit/hyperactivity disorder. Biol Psychiatry. 74:599–606.
  • Shiffrin ND, Gruber J, Glatt SJ, Faraone SV. 2013. No association between MspI allele of the ADRA2A polymorphism and ADHD: Meta-analysis of family-based studies. Psychiatr Genet. 23:174–175.
  • Shim SH, Hwangbo Y, Kwon YJ, Jeong HY, Lee BH, Lee HJ, Kim YK. 2008. Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD). Prog Neuropsychopharmacol Biol Psychiatry. 32:1824–1828.
  • Simon V, Czobor P, Bálint S, Mészáros A, Bitter I. 2009. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 194:204–211.
  • Smith TF. 2010. Meta-analysis of the heterogeneity in association of DRD4 7-repeat allele and AD/HD: stronger association with AD/HD combined type. Am J Med Genet B Neuropsychiatr Genet. 153B:1189–1199.
  • Sun H, Yuan F, Shen X, Xiong G, Wu J. 2014. Role of COMT in ADHD: a systematic meta-analysis. Mol Neurobiol. 49:251–261.
  • Taurines R, Segura M, Schecklmann M, Albantakis L, Grünblatt E, Walitza S, Jans T, Lyttwin B, Haberhausen M, Theisen FM, et al. 2011. Altered mRNA expression of monoaminergic candidate genes in the blood of children with attention deficit hyperactivity disorder and autism spectrum disorder. World J Biol Psychiatry. 12(Suppl 1):104–108.
  • Volkow ND, Swanson JM. 2013. Clinical practice: adult attention deficit-hyperactivity disorder. N Engl J Med. 369:1935–1944.
  • Weber H, Scholz CJ, Jacob CP, Heupel J, Kittel-Schneider S, Erhardt A, Hempel S, Schmidt B, Kiel T, Gessner A, et al. 2014. SPOCK3, a risk gene for adult ADHD and personality disorders. Eur Arch Psychiatry Clin Neurosci. 264:409–421.
  • Weißflog L, Scholz CJ, Jacob CP, Nguyen TT, Zamzow K, Groß-Lesch S, Renner TJ, Romanos M, Rujescu D, Walitza S, et al. 2013. KCNIP4 as a candidate gene for personality disorders and adult ADHD. Eur Neuropsychopharmacol. 23:436–447.
  • Willcutt EG. 2012. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics. 9:490–499.
  • Williams NM, Franke B, Mick E, Anney RJ, Freitag CM, Gill M, Thapar A, O'Donovan MC, Owen MJ, Holmans P, et al. 2012. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry. 169:195–204.
  • Wu J, Xiao H, Sun H, Zou L, Zhu LQ. 2012. Role of dopamine receptors in ADHD: A systematic meta-analysis. Mol Neurobiol. 45:605–620.
  • Xu X, Breen G, Chen CK, Huang YS, Wu YY, Asherson P. 2010. Association study between a polymorphism at the 3'-untranslated region of CLOCK gene and attention deficit hyperactivity disorder. Behav Brain Funct. 6:48.
  • Xu X, Breen G, Luo L, Sun B, Chen CK, Paredes UM, Huang YS, Wu YY, Asherson P. 2013. Investigation of the ZNF804A gene polymorphism with genetic risk for bipolar disorder in attention deficit hyperactivity disorder. BMC Res Notes. 6:29. doi:10.1186/1756-0500-6-29.
  • Xu Y, Chen XT, Luo M, Tang Y, Zhang G, Wu D, Yang B, Ruan DY, Wang HL. 2015. Multiple epigenetic factors predict the attention deficit/hyperactivity disorder among the Chinese Han children. J Psychiatr Res. 64:40–50.
  • Yang L, Neale BM, Liu L, Lee SH, Wray NR, Ji N, Li H, Qian Q, Wang D, Li J, et al. 2013. Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B Neuropsychiatr Genet. 162B:419–430.
  • Zhou K, Dempfle A, Arcos-Burgos M, Bakker SC, Banaschewski T, Biederman J, Buitelaar J, Castellanos FX, Doyle A, Ebstein RP, et al. 2008. Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 147B:1392–1398.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.